Evidence map›Paper›PMID 36823625›Full record

Observational studyCritical care (London, England)2023

Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit.

María Martín-Cerezuela, Maialen Aseginolaza-Lizarazu, Patricia Boronat-García, María José Asensio-Martín, Gisela Alamán-Laguarda, Francisco Álvarez-Lerma, David Roa-Alonso, Lorenzo Socias, Paula Vera-Artázcoz, Paula Ramírez-Galleymore and 1 more

Open access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Critical care (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Severe invasive pneumococcal disease beyond current vaccination recommendations: implications for higher-valency vaccines.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Global Antimicrobial Non-Susceptibility Patterns ofInfection and drug resistance · 2026
    Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

María Martín-CerezuelaIntensive Care Unit, Instituto de Investigación Sanitaria La Fe, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Maialen Aseginolaza-LizarazuIntensive Care Unit, Hospital Donostia-Donostia Ospitalea, Guipúzcoa, Spain.
Patricia Boronat-GarcíaIntensive Care Unit, Hospital Univeristari Germans Trias i Pujol, Badalona, Spain.
María José Asensio-MartínIntensive Care Unit, Hospital Universitario La Paz, Madrid, Spain.
Gisela Alamán-LaguardaIntensive Care Unit, Hospital Universitario de la Ribera, Valencia, Spain.
Francisco Álvarez-LermaIntensive Care Unit, Fundación, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, Spain.
David Roa-AlonsoIntensive Care Unit, Hospital Severo Ochoa, Madrid, Spain.
Lorenzo SociasIntensive Care Unit, Hospital Son Llàtzer, Mallorca, Spain.
Paula Vera-ArtázcozIntensive Care Unit, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Paula Ramírez-GalleymoreIntensive Care Unit, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, nº 106, CP 46026, Valencia, Spain. ramirez_pau@gva.es.ORCID 0000-0002-7598-3350
Grupo de Trabajo en Infección y Sepsis (GTEIS) from the Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC)
Hospital Universitario Severo Ochoa · ESDonostiako Unibertsitate Ospitalea · ESHospital de La Ribera · ESHospital de Sant Pau · ESHospital Son Llatzer · ESHospital Universitari Germans Trias i Pujol · ESHospital Universitari i Politècnic La Fe · ESHospital Universitario La Paz · ESInstituto de Investigación Sanitaria La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere community-acquired pneumococcal meningitis is a medical emergency. The aim of the present investigation was to evaluate the epidemiology, management and outcomes of this condition.

methodsThis was a retrospective, observational and multicenter cohort study. Sixteen Spanish intensive care units (ICUs) were included. Demographic, clinical and microbiological variables from patients with Streptococcus pneumoniae meningitis admitted to ICU were evaluated. Clinical response was evaluated at 72 h after antibiotic treatment initiation, and meningitis complications, length of stay and 30-day mortality were also recorded.

resultsIn total, 255 patients were included. Cerebrospinal fluid (CSF) culture was positive in 89.7%; 25.7% were non-susceptible to penicillin, and 5.2% were non-susceptible to ceftriaxone or cefotaxime. The most frequent empiric antibiotic regimen was third-generation cephalosporin (47.5%) plus vancomycin (27.8%) or linezolid (12.9%). A steroid treatment regimen was administered to 88.6% of the patients. Clinical response was achieved in 65.8% of patients after 72 h of antibiotic treatment. Multivariate analysis identified two factors associated with early treatment failure: invasive mechanical ventilation (OR 10.74; 95% CI 3.04-37.95, p < 0.001) and septic shock (OR 1.18; 95% CI 1.03-1.36, p = 0.017). The 30-day mortality rate was 13.7%. Only three factors were independently associated with 30-day mortality: delay in start of antibiotic treatment (OR 18.69; 95% CI 2.13-163.97, p = 0.008), Sepsis-related Organ Failure Assessment (SOFA) score (OR 1.36; 95% CI 1.12-1.66, p = 0.002) and early treatment failure (OR 21.75 (3.40-139.18), p = 0.001). Neurological complications appeared in 124 patients (48.63%).

conclusionsMortality rate in critically ill patients with pneumococcal meningitis is lower than previously reported. Delay in antibiotic treatment following admission is the only amendable factor associated with mortality.

Indexed as

Meningitis, PneumococcalAnti-Bacterial AgentsCohort StudiesHumansIntensive Care UnitsPrognosisRetrospective StudiesStreptococcus pneumoniaeAnti-Bacterial AgentsCritically illnessIntensive care unitsMeningitisStreptococcus pneumoniae

Identifiers

PMID36823625
PMCPMC9951455
OpenAlexW4321613031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.